This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Nov 10;37(32):2957-2960.

doi: 10.1200/JCO.19.01863. Epub 2019 Sep 4.

Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive Paradigm

Channing J Paller¹, Mario A Eisenberger¹

Affiliations

PMID: 31483709
DOI: 10.1200/JCO.19.01863

Editorial

Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive Paradigm

Channing J Paller et al. J Clin Oncol. 2019.

. 2019 Nov 10;37(32):2957-2960.

doi: 10.1200/JCO.19.01863. Epub 2019 Sep 4.

Authors

Channing J Paller¹, Mario A Eisenberger¹

Affiliation

¹ Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

PMID: 31483709
DOI: 10.1200/JCO.19.01863

No abstract available

PubMed Disclaimer

Comment on

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer.
Armstrong AJ, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Rosbrook B, Sugg J, Baron B, Chen L, Stenzl A. Armstrong AJ, et al. J Clin Oncol. 2019 Nov 10;37(32):2974-2986. doi: 10.1200/JCO.19.00799. Epub 2019 Jul 22. J Clin Oncol. 2019. PMID: 31329516 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information